Tango Therapeutics (TNGX) Competitors $4.74 +0.27 (+6.04%) Closing price 06/11/2025 04:00 PM EasternExtended Trading$4.62 -0.12 (-2.43%) As of 07:29 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock TNGX vs. AUPH, CVAC, MLYS, PAHC, WVE, RCUS, SNDX, COLL, ELVN, and SYREShould you be buying Tango Therapeutics stock or one of its competitors? The main competitors of Tango Therapeutics include Aurinia Pharmaceuticals (AUPH), CureVac (CVAC), Mineralys Therapeutics (MLYS), Phibro Animal Health (PAHC), Wave Life Sciences (WVE), Arcus Biosciences (RCUS), Syndax Pharmaceuticals (SNDX), Collegium Pharmaceutical (COLL), Enliven Therapeutics (ELVN), and Spyre Therapeutics (SYRE). These companies are all part of the "pharmaceutical products" industry. Tango Therapeutics vs. Its Competitors Aurinia Pharmaceuticals CureVac Mineralys Therapeutics Phibro Animal Health Wave Life Sciences Arcus Biosciences Syndax Pharmaceuticals Collegium Pharmaceutical Enliven Therapeutics Spyre Therapeutics Aurinia Pharmaceuticals (NASDAQ:AUPH) and Tango Therapeutics (NASDAQ:TNGX) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their dividends, community ranking, media sentiment, earnings, institutional ownership, analyst recommendations, risk, valuation and profitability. Does the media prefer AUPH or TNGX? In the previous week, Tango Therapeutics had 4 more articles in the media than Aurinia Pharmaceuticals. MarketBeat recorded 13 mentions for Tango Therapeutics and 9 mentions for Aurinia Pharmaceuticals. Aurinia Pharmaceuticals' average media sentiment score of 1.63 beat Tango Therapeutics' score of 1.11 indicating that Aurinia Pharmaceuticals is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Aurinia Pharmaceuticals 4 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Tango Therapeutics 4 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Does the MarketBeat Community favor AUPH or TNGX? Aurinia Pharmaceuticals received 548 more outperform votes than Tango Therapeutics when rated by MarketBeat users. However, 74.36% of users gave Tango Therapeutics an outperform vote while only 73.41% of users gave Aurinia Pharmaceuticals an outperform vote. CompanyUnderperformOutperformAurinia PharmaceuticalsOutperform Votes57773.41% Underperform Votes20926.59% Tango TherapeuticsOutperform Votes2974.36% Underperform Votes1025.64% Which has more volatility and risk, AUPH or TNGX? Aurinia Pharmaceuticals has a beta of 1.15, meaning that its share price is 15% more volatile than the S&P 500. Comparatively, Tango Therapeutics has a beta of 1.24, meaning that its share price is 24% more volatile than the S&P 500. Which has higher earnings & valuation, AUPH or TNGX? Aurinia Pharmaceuticals has higher revenue and earnings than Tango Therapeutics. Tango Therapeutics is trading at a lower price-to-earnings ratio than Aurinia Pharmaceuticals, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAurinia Pharmaceuticals$247.30M4.42-$78.02M$0.2828.89Tango Therapeutics$40.99M12.53-$101.74M-$1.22-3.89 Is AUPH or TNGX more profitable? Aurinia Pharmaceuticals has a net margin of -10.23% compared to Tango Therapeutics' net margin of -284.42%. Aurinia Pharmaceuticals' return on equity of -4.41% beat Tango Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Aurinia Pharmaceuticals-10.23% -4.41% -3.07% Tango Therapeutics -284.42%-49.64%-32.00% Do analysts rate AUPH or TNGX? Aurinia Pharmaceuticals currently has a consensus price target of $11.50, indicating a potential upside of 42.15%. Tango Therapeutics has a consensus price target of $12.20, indicating a potential upside of 157.38%. Given Tango Therapeutics' higher probable upside, analysts clearly believe Tango Therapeutics is more favorable than Aurinia Pharmaceuticals.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Aurinia Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00Tango Therapeutics 0 Sell rating(s) 0 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 3.00 Do institutionals & insiders believe in AUPH or TNGX? 36.8% of Aurinia Pharmaceuticals shares are held by institutional investors. Comparatively, 79.0% of Tango Therapeutics shares are held by institutional investors. 12.2% of Aurinia Pharmaceuticals shares are held by insiders. Comparatively, 6.3% of Tango Therapeutics shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. SummaryAurinia Pharmaceuticals beats Tango Therapeutics on 9 of the 17 factors compared between the two stocks. Get Tango Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for TNGX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding TNGX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TNGX vs. The Competition Export to ExcelMetricTango TherapeuticsPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$513.79M$6.85B$5.57B$8.63BDividend YieldN/A2.55%5.28%4.18%P/E Ratio-4.028.7827.1320.06Price / Sales12.53255.64412.28157.10Price / CashN/A65.8538.2534.64Price / Book1.916.557.064.70Net Income-$101.74M$143.93M$3.23B$247.88M7 Day Performance35.04%3.84%2.86%2.63%1 Month Performance261.83%11.20%9.05%6.36%1 Year Performance-37.71%4.18%31.39%14.05% Tango Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TNGXTango Therapeutics2.1608 of 5 stars$4.74+6.0%$12.20+157.4%-31.5%$513.79M$40.99M-4.0290News CoveragePositive NewsAnalyst RevisionGap UpHigh Trading VolumeAUPHAurinia Pharmaceuticals3.3372 of 5 stars$7.96+1.5%$11.50+44.5%+45.8%$1.08B$247.30M-53.06300Positive NewsAnalyst RevisionCVACCureVac4.4171 of 5 stars$4.63+3.6%$11.00+137.6%-4.2%$1.04B$523.70M8.42880Positive NewsMLYSMineralys Therapeutics3.3374 of 5 stars$15.70+0.8%$38.00+142.0%+19.7%$1.02BN/A-4.3128Positive NewsAnalyst ForecastPAHCPhibro Animal Health3.8832 of 5 stars$24.58+0.7%$20.00-18.6%+45.6%$996.33M$1.19B51.211,860Positive NewsWVEWave Life Sciences4.4485 of 5 stars$6.25+4.0%$21.17+238.7%+16.0%$963.34M$104.94M-5.63240News CoveragePositive NewsAnalyst ForecastAnalyst RevisionRCUSArcus Biosciences2.5657 of 5 stars$9.21+3.1%$24.13+162.1%-41.9%$945.55M$141M-2.92500Options VolumeAnalyst RevisionGap UpSNDXSyndax Pharmaceuticals3.0257 of 5 stars$10.98+4.2%$35.91+227.0%-43.6%$944.80M$43.72M-3.02110Positive NewsCOLLCollegium Pharmaceutical4.0333 of 5 stars$29.31+0.6%$43.80+49.4%-8.8%$941.79M$664.28M12.63210Positive NewsInsider TradeELVNEnliven Therapeutics2.4734 of 5 stars$19.14+7.7%$37.25+94.6%-10.9%$939.18MN/A-10.0750Insider TradeSYRESpyre Therapeutics2.4074 of 5 stars$15.40+0.8%$53.40+246.8%-52.6%$928.25M$890K-2.0673Positive News Related Companies and Tools Related Companies AUPH Competitors CVAC Competitors MLYS Competitors PAHC Competitors WVE Competitors RCUS Competitors SNDX Competitors COLL Competitors ELVN Competitors SYRE Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:TNGX) was last updated on 6/12/2025 by MarketBeat.com Staff From Our PartnersTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredBig Changes Coming to Social Security?According to legendary investor Louis Navellier... This new Trump move could soon not only save Social Secu...InvestorPlace | SponsoredSHOCKING: Musk's Pentagon Secret Mission...It's about a harrowing message discovered on December 16, 2024: "美国军方暗杀名单" It's the reason President Tru...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tango Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Tango Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
